# The Effects of Corneal Collagen Cross-linking

> **NCT01708538** · PHASE3 · UNKNOWN · sponsor: **Rush Eye Associates** · enrollment: 30 (estimated)

## Conditions studied

- Corneal Ectasia Disorders Including Keratoconus

## Interventions

- **DRUG:** CXL

## Key facts

- **NCT ID:** NCT01708538
- **Lead sponsor:** Rush Eye Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01708538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01708538, "The Effects of Corneal Collagen Cross-linking". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01708538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*